Ongoing Communication with FDA to Align on Next Steps for Larsucosterol in Alcohol-Associated Hepatitis Webcast of Earnings Call Today, March 27th at 4:30 p.m. ET CUPERTINO, Calif. , March 27, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the fourth quarter and year ended December 31, 2023 and provided a business update. "We remain enthusiastic about the improvement in 90-day... Read More